Pregnancy outcomes after stoma surgery for inflammatory bowel disease: The results of a retrospective multicentre audit.

"CONFLICT OF INTERESTS SB is the Digital Marketing Manager for Bullen Healthcare, a Dispensing Appliance Contractor. This work was carried out in a personal capacity and in her own time and reflects personal views and not those of her employer. CPS has received unrestricted research grants from Janssen and, AbbVie, has provided consultancy to Arena, Galapagos, Dr Falk, AbbVie, Takeda, Fresenius Kabi and Janssen, and had speaker arrangements with Celltrion, Dr Falk, AbbVie, Janssen, Pfizer and Takeda. MJB reports grants from Vifor International and Tillotts Pharma, travel costs and meeting expenses from Tillotts Pharma, and personal fees from Vifor International, outside the submitted work. PC has received speaker fees from Shire, Abbvie, MSD, Warner‐Chillcott and Falk pharma. He has received educational grants from Warner Chilcott, MSD and Ferring pharmaceuticals. He has served as an Advisory Board member for Falk pharma. SD received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Takeda, Dr Falk. SD received support for attending meetings and/or travel from Abbvie, Takeda, Dr Falk, Janssen. RC received speaker/advisory board fees from Falk, Takeda, Ferring and Janssen. KBK received honoraria for consultancy from Amgen, Janssen, and PredictImmune, for speaker arrangements from Takeda, and Janssen and support for conference attendance fees from Janssen, and Takeda. All other authors declare no conflict of interest."

"Funding information"